A more recent edition of NAICS is available.
2017 Edition

national industry 325414

Biological Product (except Diagnostic) Manufacturing

Overview

This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

The immediate parent of national industry 325414 is international industry 32541: Pharmaceutical and Medicine Manufacturing

2017 NAICS Edition Cross References

  • Manufacturing in-vitro diagnostic substances--are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing; and
  • Manufacturing pharmaceutical preparations (except biological and in-vitro diagnostic substances)- -are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.

Sub-Descriptions

  1. 325414 - Agar culture media manufacturing
  2. 325414 - Aggressins (except in-vitro) manufacturing
  3. 325414 - Allergenic extracts (except diagnostic substances) manufacturing
  4. 325414 - Allergens manufacturing
  5. 325414 - Antigens manufacturing
  6. 325414 - Antiserums manufacturing
  7. 325414 - Antitoxins manufacturing
  8. 325414 - Antivenoms manufacturing
  9. 325414 - Bacterial vaccines manufacturing
  10. 325414 - Bacterins (i.e., bacterial vaccines) manufacturing
  11. 325414 - Blood derivatives manufacturing
  12. 325414 - Blood fractions manufacturing
  13. 325414 - Cholera serums manufacturing
  14. 325414 - Culture media manufacturing
  15. 325414 - Gene therapy preparations manufacturing
  16. 325414 - Hematology products (except diagnostic substances) manufacturing
  17. 325414 - Plasmas manufacturing
  18. 325414 - Serums (except diagnostic substances) manufacturing
  19. 325414 - Toxoids (e.g., diphtheria, tetanus) manufacturing
  20. 325414 - Tuberculin (i.e., tuberculo-protein derived) manufacturing
  21. 325414 - Vaccines (i.e., bacterial, virus) manufacturing
  22. 325414 - Virus vaccines manufacturing

History

The NAICS editions in which this code was present are indicated below. In the event that a code was changed from the prior edition the equivalent value in that edition is provided for reference.

Edition Existed Equivalent Value
2002 325414
2007 325414
2012 325414
2017 325414
2022 325414

Standard Industrial Classification (SIC) Mappings

  1. 2836 - Biological Products, Except Diagnostic Substances

Insurance Industry Mappings

The US Property and Casualty Insurance Industry may use the following classification descriptions which might encompass national industry 325414, Biological Product (except Diagnostic) Manufacturing:

  1. antitoxin serum or virus manufacturing
  2. biological product except diagnostic manufacturing
  3. biological product except diagnostic substance
  4. chemical manufacturing
  5. chemical manufacturing comm or ind primarily toxic or a health hazard not otherwise classified
  6. chemical manufacturing comm or indust primarily flammable or explosive or reactive not otherwise classified
  7. chemical manufacturing comm or indust toxic or flammable or explosive or reactive not otherwise classified
  8. chemical manufacturing commercial or industrial
  9. chemical manufacturing commercial or industrial not otherwise classified
  10. chemical manufacturing commercial or industrial primarily flammable explosive of reactive not otherwise classified
  11. chemical manufacturing commercial or industrial primarily flammable explosive or reactive
  12. chemical manufacturing commercial or industrial primarily toxic or presenting a health hazard
  13. chemical manufacturing commercial or industrial primarily toxicor presenting a health hazard not otherwise classified
  14. chemical manufacturing commercial or industrial toxic and either flammable explosive or reactive
  15. chemical manufacturing commercial or industrial toxic and eitherflammable explosive or reactive not otherwise classified
  16. chemical manufacturing household
  17. chemical manufacturing household not otherwise classified
  18. chemical manufacturing household primarily flammable explosive or reactive
  19. chemical manufacturing household primarily flammable explosiveor reactive not otherwise classified
  20. chemical manufacturing household primarily flammable or explosive or reactive not otherwise classified
  21. chemical manufacturing household primarily toxic or a health hazard not otherwise classified
  22. chemical manufacturing household primarily toxic or presenting a health hazard
  23. chemical manufacturing household primarily toxic or presenting ahealth hazard not otherwise classified
  24. chemical manufacturing household toxic and either flammable explosive or reactive
  25. chemical manufacturing household toxic and either flammable explosiveor reactive not otherwise classified
  26. chemical manufacturing household toxic or flammable or explosive or reactive not otherwise classified
  27. chemical not otherwise classified high hazard
  28. chemical not otherwise classified low hazard
  29. chemical not otherwise classified moderate hazard
  30. drug manufacturing biological product
  31. drug medicine and pharmaceutical preparation compounding orblending no manufacturing of ingredient
  32. drug medicine or pharmaceutical preparation manufacturing com
  33. drug medicine or pharmaceutical preparation manufacturing compounding blending or packaging only not manufacturing ingredient not otherwise classified
  34. drug medicine or pharmaceutical preparation no manufacturing of ingredient
  35. drug medicine or pharmaceutical preparation not manufacturing of ingredient
  36. manufacturing
  37. medicine drug or pharmaceutical preparation compounding or blending no manufacturing of ingredient
  38. medicine drug or pharmaceutical preparation no manufacturing of ingredient
  39. pharmaceutical and medicine manufacturing
  40. pharmaceutical drug or medicine preparation no manufacturing of ingredient
  41. pharmaceutical drug or medicine preparation no manufacturing ofingredient
  42. serum antitoxin or virus manufacturing

Downloads

What's the difference between HD and SD? See our methodology.